KRRO - Korro Bio, Inc.

QQQ $ 452.83 $ 3.91 (0.87 %)

DIA $ 399.31 $ 3.70 (0.94 %)

SPY $ 529.09 $ 3.17 (0.6 %)

TLT $ 92.14 $ 1.28 (1.41 %)

GLD $ 220.89 $ 2.80 (1.28 %)

Previous Close

$ 52.77

Open

$ 50.98

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 50.47 - $ 52.65

52 Week Range

$ 0.18 - $ 97.91

Volume

27,027

Average Volume

Market Cap

401.38M

Beta (5Y Monthly)

$ 9.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-26-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-12-2023	03-31-2023	10-Q
6	03-10-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	03-15-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-29-2021	12-31-2020	10-K
15	11-16-2020	09-30-2020	10-Q
16	08-12-2020	06-30-2020	10-Q
17	05-14-2020	03-31-2020	10-Q
18	03-26-2020	12-31-2019	10-K
19	11-18-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Korro...
05/15/2024 15:11:37

HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and lowers the price target fro...

BMO Capital Maintains Outperform on Korro ...
05/15/2024 13:02:21

BMO Capital analyst Kostas Biliouris maintains Korro Bio (NASDAQ:KRRO) with a Outperform and maintains $120 price target.

Korro Bio Q1 2024 Adj EPS $(2.44) Beats $(...
05/14/2024 20:20:30

Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(2.44) per share which beat the analyst consensus estimate of $(2.51) by ...

Korro Announces $70M Private Placement
04/18/2024 12:32:40

Financing led by Deep Track Capital with participation from other leading healthcare investorsPro-forma cash and cash equivalen...

HC Wainwright & Co. Maintains Buy on Korro...
03/28/2024 10:24:42

HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and raises the price target fro...

Piper Sandler Maintains Overweight on Korr...
03/27/2024 16:46:12

Piper Sandler analyst Yasmeen Rahimi maintains Korro Bio (NASDAQ:KRRO) with a Overweight and maintains $180 price target.

RBC Capital Maintains Outperform on Korro ...
03/27/2024 14:38:00

RBC Capital analyst Luca Issi maintains Korro Bio (NASDAQ:KRRO) with a Outperform and raises the price target from $70 to $90.

Korro FY23 EPS $(53.08) Vs $(227.42) YoY
03/26/2024 20:16:38

Full Year 2023 Financial Results:Cash Position: Cash, cash equivalents and short-term investments were $166.1 million as of Dec...

BMO Capital Reiterates Outperform on Korro...
03/26/2024 11:48:08

BMO Capital analyst Kostas Biliouris reiterates Korro Bio (NASDAQ:KRRO) with a Outperform and maintains $120 price target.

RBC Capital Reiterates Outperform on Korro...
03/12/2024 15:21:34

RBC Capital analyst Luca Issi reiterates Korro Bio (NASDAQ:KRRO) with a Outperform and maintains $70 price target.

BMO Capital Initiates Coverage On Korro Bi...
02/27/2024 10:47:10

BMO Capital analyst Kostas Biliouris initiates coverage on Korro Bio (NASDAQ:KRRO) with a Outperform rating and announces Pr...

Ecolab Posts Strong Results, Joins Masonit...
02/13/2024 15:09:30

U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.

HC Wainwright & Co. Reiterates Buy on Korr...
01/19/2024 11:35:39

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Korro Bio (NASDAQ:KRRO) with a Buy and maintains $100 price target.

Korro Bio Highlights Data For Its Lead Pro...
01/18/2024 13:12:32

KRRO-110 has a potentially best-in-class profile with secretion of ~50µM functional AAT protein after a single dose in a precli...

Korro Announces Selection Of Its First Dev...
12/07/2023 13:10:37

KRRO-110 is the first RNA editing oligonucleotide candidate from Korro's proprietary OPERA™ platform Korro has demonstrated...

why-newly-listed-korro-bio-shares-are-gaining-today

Why Newly Listed Korro Bio Shares Are Gain...
12/04/2023 19:34:25

H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused on e...

HC Wainwright & Co. Initiates Coverage On ...
12/04/2023 11:50:48

HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Korro Bio (NASDAQ:KRRO) with a Buy rating and announce...

RBC Capital Initiates Coverage On Korro Bi...
11/29/2023 11:03:35

RBC Capital analyst Luca Issi initiates coverage on Korro Bio (NASDAQ:KRRO) with a Outperform rating and announces Price Tar...

chegg-perdoceo-education-and-other-big-stocks-moving-lower-on-monday

Chegg, Perdoceo Education And Other Big St...
11/20/2023 15:51:11

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in t...

Piper Sandler Initiates Coverage On Korro ...
11/10/2023 11:24:31

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Korro Bio (NASDAQ:KRRO) with a Overweight rating and announces Pr...